The FDA now issues the strictest warning on Avandia due to heart risks. In the New England Journal of Medicine, and article was written discussing the safety issues regarding Avandia (Rosiglitazone).
There was 40 clinical studies performed, and this extensive analysis raised concerns about the potential heart complications associated with Avandia. Avandia significantly increases risk of heart attack, so the FDA now recommends that all users talk to their doctor.
If you or a loved one has taken Avandia then contact us today. We can help.
For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.